Developing new contraceptive methods for women, especially those who are obese.
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - EMORY
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-11132563
This study is looking for ways to create safer birth control options that help prevent unintended pregnancies while also reducing the risk of blood clots, especially for women who are obese, and by joining in, you can help improve these options for everyone.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11132563 on ClinicalTrials.gov |
What this research studies
This research focuses on creating new contraceptive methods that not only prevent unintended pregnancies but also minimize the risk of venous thromboembolism (VTE), particularly in obese women. The Contraceptive Clinical Trials Network (CCTN) is dedicated to developing protocols and conducting clinical trials aimed at ensuring the safety and effectiveness of these contraceptives. By participating in this program, patients may contribute to the advancement of contraceptive options that cater to their specific health needs.
Who could benefit from this research
Good fit: Ideal candidates for this research include women seeking effective contraception, especially those who are obese or have medical conditions that make current contraceptive methods unsuitable.
Not a fit: Patients who are not seeking contraception or who do not have concerns related to obesity or contraindications with current contraceptive methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective contraceptive options for women, particularly those at higher risk due to obesity.
How similar studies have performed: Previous research has shown promise in developing new contraceptive methods, but this specific approach targeting obese women is relatively novel.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CWIAK, CARRIE — EMORY UNIVERSITY
- Study coordinator: CWIAK, CARRIE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.